FeLV and haemoplasma IgM positivity in a hospital sample of cats in Portugal

Companion animal health and genetics · 2026

In plain language

In a hospital study in Portugal, 32 of 134 cats tested positive for IgM antibodies against haemoplasmas. No statistically significant link was found between having FeLV and testing positive, but only six cats had FeLV: the results do not show that there is no link or that FeLV has a protective effect. A positive test was the study's criterion for classifying acute mycoplasmosis, not independent confirmation of active clinical disease in each cat. The study did not evaluate interventions targeting FeLV or the course of FeLV disease.

Scientific detail

The clinical study, published in 2026 in Companion animal health and genetics, used an analytical cross-sectional observational design in a hospital sample of 134 cats in Portugal. It classified acute feline mycoplasmosis using a positive haemoplasma IgM result. There were 32 IgM-positive and 102 IgM-negative cats; the reported observed prevalence of positivity was 23.8%, with a 95% confidence interval of 0.169–0.320. This frequency applies to the screened hospital patients; it is neither a representative estimate for all cats in Portugal nor a measure of FeLV prevalence. The operational definition also does not independently confirm active clinical disease in every IgM-positive cat.

FeLV status was available for 124 cats, including six FeLV-positive cats, one of whom was IgM-positive. Univariate analysis identified no statistically significant association between FeLV status and haemoplasma IgM positivity: OR 0.587, 95% CI 0.066–5.22, p = 1. The small FeLV-positive subgroup and wide confidence interval do not establish a protective effect of FeLV or the absence of an association. The FIV finding is distinct and cannot substitute for a FeLV finding. Prognostic analyses included the 32 IgM-positive cats; the study did not evaluate FeLV-directed interventions or FeLV disease progression.

The authors could not identify the Mycoplasma species affecting individual cats or distinguish single haemoplasma infections from coinfections. The reported associations therefore cannot be assigned to a particular species or to single versus mixed infections; this limitation does not mean that recorded FIV or FeLV status was unavailable for every cat. They also reported a lack of laboratory standardization and missing information in retrospective records. The abstract acknowledges that direct causality cannot be inferred. The claims presented are assigned evidence level C and derive from an observational hospital sample, not a controlled experiment.

What we know

In this hospital sample, 32 of 134 cats were haemoplasma IgM-positive; the reported observed prevalence was 23.8% (95% CI 0.169–0.320). The study used this positivity to classify acute mycoplasmosis. Among the 124 cats with recorded FeLV status, six were FeLV-positive and one of those six was IgM-positive. Univariate analysis detected no statistically significant association between FeLV and IgM positivity (OR 0.587; 95% CI 0.066–5.22; p = 1). This is level C observational evidence.

What we don't know

These data do not establish whether an association exists between FeLV and haemoplasma IgM positivity, nor do they demonstrate a protective effect of FeLV. The Mycoplasma species involved were not identified, and single haemoplasma infections were not distinguished from coinfections. IgM-based classification does not independently confirm active clinical disease in each positive cat. Direct causality cannot be inferred, and the observed frequency cannot be extrapolated to all cats in Portugal. The study provides no evaluation of FeLV-directed interventions or FeLV disease progression.

Evidence

EvidenceLevel C — Preliminary evidenceConfidence 100/100

The authors could not identify the Mycoplasma species affecting individual cats or distinguish haemoplasma coinfections from single infections.

Excerpt verified in the source — verbatim, in the source's own language“This study was hampered by a few limitations, the main difficulty being the lack of information regarding the species of Mycoplasma affecting each patient and the inability to distinguish cases of co-infection from single infection cases.”

The reported associations cannot be assigned to a particular haemoplasma species or to single versus mixed haemoplasma infections. This limitation does not mean that recorded FIV or FeLV status was unavailable for every cat.

EvidenceLevel C — Preliminary evidenceConfidence 100/100

FeLV status was not significantly associated with haemoplasma IgM positivity in the univariate analysis: OR 0.587, 95% CI 0.066–5.22, p = 1.

Excerpt verified in the source — verbatim, in the source's own language“FeLV (F) 124 Negative 118 88 (74.6) 30 (25.4) 0.587 0.066–5.22 1 Positive 6 5 (83.3) 1 (16.7)”

Table 3 reports only six FeLV-positive cats, of whom one was IgM-positive. The wide confidence interval and nonsignificant result do not establish either a protective effect of FeLV or absence of an association.

EvidenceLevel C — Preliminary evidenceConfidence 100/100

The study reports haemoplasma IgM positivity in 32 of 134 screened cats, with an observed prevalence of 23.8% and a 95% confidence interval of 0.169–0.320.

Excerpt verified in the source — verbatim, in the source's own language“Of the 134 cats tested for haemoplasma at the HEV, 32 had positive IgM results, while 102 had negative IgM results, therefore the observed prevalence was 23.8% (95% CI: 0.169–0.320).”

This is the reported frequency of IgM positivity in screened hospital patients, not a population-representative estimate for all Portuguese cats or a measure of FeLV prevalence.

EvidenceLevel C — Preliminary evidenceConfidence 100/100

The study used an analytical cross-sectional design and classified acute feline mycoplasmosis by a positive IgM result.

Excerpt verified in the source — verbatim, in the source's own language“An analytical cross-sectional study was devised with the target population set as HEV feline patients who underwent feline mycoplasmosis screening, between January 1st, 2021, and June 30th, 2024. The criterion used to classify a case as an acute feline mycoplasmosis infection was the presence of a positive Immunoglobulin M (IgM) result.”

This describes the study design and operational case definition, not independent confirmation that every IgM-positive cat had active clinical disease. The evidence is observational rather than controlled experimental evidence.

Provenance

Source: Feline haemotropic Mycoplasma spp. in Portugal: association with identifiable risk factors, clinical parameters and prognostic factors.
DOI: 10.1186/s40575-026-00157-2
Generated by: AVAPROJECT-VIROLOGY-001
Critiqued by: AVAPROJECT-CRITIC-001
Model: openai-codex
Updated:

This project does not diagnose or prescribe. Always consult your veterinarian.